PENTIMALLI , FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.377
EU - Europa 353
AS - Asia 40
SA - Sud America 2
Totale 2.772
Nazione #
US - Stati Uniti d'America 2.371
DE - Germania 195
IT - Italia 78
BE - Belgio 35
SG - Singapore 25
CZ - Repubblica Ceca 9
FI - Finlandia 8
PK - Pakistan 8
CA - Canada 6
GB - Regno Unito 5
SE - Svezia 5
PL - Polonia 4
UA - Ucraina 4
CN - Cina 2
IR - Iran 2
MD - Moldavia 2
NL - Olanda 2
RU - Federazione Russa 2
AT - Austria 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
IN - India 1
MT - Malta 1
PE - Perù 1
RO - Romania 1
TW - Taiwan 1
Totale 2.772
Città #
Chandler 876
Lawrence 151
Princeton 151
Munich 138
Ashburn 135
Hanover 51
Las Vegas 50
Brussels 35
Miami 23
Seattle 23
Boardman 21
Singapore 17
Atlanta 11
Brno 9
Helsinki 8
Napoli 8
Bari 6
Islamabad 6
Naples 6
Phoenix 5
Borås 4
Catania 4
Birmingham 3
Gastonia 3
Hemsbach 3
Salt Lake City 3
Turin 3
Aversa 2
Bologna 2
Calgary 2
Chisinau 2
Clearwater 2
Council Bluffs 2
Francavilla Fontana 2
Ischia 2
Lahore 2
Milan 2
Noicattaro 2
Padova 2
Rome 2
Santa Clara 2
Santo Stefano del Sole 2
Scilla 2
Trento 2
Trumbull 2
Vercelli 2
Warsaw 2
Buffalo 1
Cedar Knolls 1
Chengdu 1
Clifton 1
Crispiano 1
Delhi 1
Ficarazzi 1
Fisciano 1
Hamrun 1
Iesi 1
Kuala Belait 1
Lima 1
Montevarchi 1
Mountain View 1
Novokuznetsk 1
Pescara 1
Philadelphia 1
Piteşti 1
Rockville 1
Siena 1
South San Francisco 1
Stockholm 1
The Dalles 1
Tower Hamlets 1
Vancouver 1
Verona 1
Totale 1.819
Nome #
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma (Cell Death & Disease, (2020), 11, 9, (748), 10.1038/s41419-020-02940-w) 37
Developmental biology: Unleashing regenerative potential 31
Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells 31
The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions 30
MicroRNAs: unicellular organisms also have their share 28
Cancer stem cells: Fishing for clues. 27
Leukaemia stem cells: More frequent and more mature. 27
Chromosome biology: Helping homologues to find their partners 27
Reactivating RBL2/p130 oncosuppressive function as a new, possible antitumoral strategy 27
Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation 27
HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression 27
Tumour suppressors: The dark side of p27 26
Immunotherapy: Beneficial loss 26
“Epigenetic modulation in cell development and differentiation.” 26
Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias 26
RNA world: Alternative routes. Nature Reviews Cancer 7, 405 25
Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients 25
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 25
The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach 25
Gene regulation: Transcription and translation get together. 24
Technology: (Truly) on and off at the flick of a switch 24
The oncolytic virus dl922-947 triggers immunogenic cell death in mesothelioma and reduces Xenograft growth 24
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2 24
A pilot study on the impact of known drug-drug interactions in cancer patients. 24
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino 24
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma 24
Circadian genetics: Setting the pace: three's company 23
Viral tumorigenesis: Viral hijacking. 23
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition 23
HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia 23
Let-7d miRNA shows both antioncogenic and oncogenic functions in osteosarcoma-derived 3AB-OS cancer stem cells. 23
A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas 23
Autophagy in disease: hunger for translation 23
Predicting breast cancer outcome: Traditional prognosticators still on center stage 23
BCL2: a 30-year tale of life, death and much more to come 23
Flavopiridol: An old drug with new perspectives? Implication for development of new drugs 23
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy 23
The Role of FBXW7 in Gynecologic Malignancies 22
Disease genetics: A pathway to complexity 22
Plant genomics: Variation patterns 22
Complete Darwin on the web. 22
The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene 22
Mass spectrometry-based proteomics: The road to lung cancer biomarker discovery 22
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas 22
New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization 22
Promises and drawbacks of targeting cell cycle kinases in cancer 22
HMGA1 protein is a novel target of the ATM kinase 22
Tumour immunotherapy: Shifting the balance. 22
RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways 22
Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines 22
CCNA1 (cyclin A1) 21
Lung cancer: Expanding the range 21
Metastasis: Breaking and entering. 21
High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases 21
Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma 21
Developmental biology: Homeobox genes: eyeing the clock. 21
Virotherapy: From single agents to combinatorial treatments 21
Incidence rate and management of diaphragmatic injury during laparoscopic nephrectomies: single-center experience 20
Cancer stem cells: BMPs on the brain 20
Tumorigenesis: Branching defects. 20
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2) 20
Oncolytic viruses as a possible therapeutic strategy against malignant mesothelioma 20
Calretinin Immunoreactivity in the Human Testis Throughout Fetal Life 20
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition 20
Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience 20
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma 20
Inducing the uptake of the deadly executioner in cancer cells 20
Camera takes its shot. 20
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review) 20
Breast cancer: A useful combination 19
Chromosomal instability: Going to any length. 19
RBL2/p130: a direct AKT substrate and mediator of AKT inhibition-induced apoptosis 19
HMGA1 protein is a novel target of the ATM kinase 19
NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer 19
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells 19
Translating RB1 predictive value in clinical cancer therapy: Are we there yet? 19
The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues 19
Abrogating G 2/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma. 19
Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 19
TRANSCRIPTIONAL PROFILE OF KI-RAS-INDUCED TRANSFORMATION OF THYROID CELLS 19
Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer 19
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation 19
Technology: On the trail of transcription factors 19
Epigenetics: 'Paternal' guidance. 19
Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate? 19
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations 18
RB dysfunction in cancer 18
Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation 18
SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration 18
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas 18
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy 18
TRANSCRIPTIONAL PROFILE OF KI-RAS-INDUCED TRANSFORMATION OF THYROID CELLS 18
NONO regulates the intra-S-phase checkpoint in response to UV radiation. 18
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage 18
ATP-noncompetitive CDK inhibitors for cancer therapy: an overview 18
New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells 18
Retinoblastoma beyond RB1 — recent advances in genetic biomarkers 18
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience 18
pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer 18
Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma 18
Totale 2.191
Categoria #
all - tutte 48.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022269 0 0 0 0 0 0 134 6 77 32 16 4
2022/20232.014 321 2 13 308 246 316 4 176 319 87 198 24
2023/2024670 56 122 49 36 92 97 38 5 131 11 3 30
2024/202550 12 31 4 3 0 0 0 0 0 0 0 0
Totale 3.003